Morning @Lastly
re: "It was certainly disappointing reading about these "minor impurities" in the first batch..."
Given the concern about these 'impurities', I think it's worth spelling out that this is an entirely normal occurance. Almost no drug is completely pure - even if it contains 99.999 percent pure API and intended ingredients (excipients, preservatives, polish for the coating, etc.) the drug sponsor or manufacturer will be required to characterise the 0.001 percent that is "impurities" when submitting their master drug file.
Impurities can occur in many different ways - for example, as a product of the manufacturing process or degradation of the drug over time while it sits on the shelf. The TGA expects this, which is why it is a requirement for these impurities to be properly characterised as part of the approval process. If anyone's interested, you can read more here:
https://www.tga.gov.au/sites/default/files/information_required_in_an_evaluient_in_listed_medicines_guidance_for_sponsors.pdf
https://www.tga.gov.au/sites/default/files/pm-argpm-guidance-11.pdf
It's mention in the release would seem benign to anyone familiar with the approval process but has clearly raised red flags for investors. Unfortunately, another case of poor messaging - while what was said is totally acurate, it seems that inadequate consideration was given to how the message would be interpreted by the casual reader (most investors).
Cheers
Densy
- Forums
- ASX - By Stock
- PAA
- Ann: MPL tablets arrive in Melbourne for MND Clinical Trial
Ann: MPL tablets arrive in Melbourne for MND Clinical Trial, page-35
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $111.9M |
Open | High | Low | Value | Volume |
21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 93524 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 71004 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 93524 | 0.225 |
9 | 434233 | 0.220 |
7 | 714363 | 0.215 |
5 | 342677 | 0.210 |
2 | 98485 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 71004 | 2 |
0.235 | 170709 | 3 |
0.240 | 214527 | 3 |
0.250 | 296054 | 5 |
0.260 | 410162 | 3 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online